Immune Response Antibody Response Vaccine Efficacy Vaccine Development Immune System Cytokines Regulatory T Cells Autoimmune Diseases Vaccines Inflammation T Cells Vaccine Research Immune System Disorders Tumor Immunology Antibodies Immunosuppression Vaccination Immunotherapy Transplant Rejection Clinical Trials Neutrophils Allergic Reactions White Blood Cells Allergic Conditions Viral Infections Innate Immunity Cancer Immunotherapy Type 2 Inflammation Transplantation Live Vaccines Tumor Microenvironment Immune Cells Tumor Antigens Combination Therapies T-lymphocytes Organ Transplants Inflammatory Diseases IgG Autoantibodies Cellular Immunity Immune Disorders Antiviral Response Influenza Viruses Chronic Inflammatory Conditions Organ Rejection Hypoimmune Cells Immunreaktion IgE-mediated Allergies Antibody Therapy Vaccine Safety Infectious Disease Modeling Genetic Mutations Therapeutics Ageing Cancer Transplant Immunology Gut Health Vaccine Effectiveness Immunological Memory T Cell Function Thymus Protein-based Vaccines Immunotherapy Strategies Interleukins Bacterial Therapies Virus Strains Influenza Vaccine Response Memory B Cells Immunization Antivenom Research Gut Microbiome Immune Evasion B-cells T Cell Activation Th2 Diseases Live Attenuated Vaccines Immune-inflammatory diseases Adaptive Immune Response Immunomodulation T-cell Therapy Mast Cells Drug Mechanisms Autoimmunity
The randomized trial ties ventral tegmental area activation to higher antibody levels, pointing to a possible neural pathway for expectation effects.
